Lenalidomide-nativ - analogs
Components: Lenalidomide |
|||||||||
Pharmgroups: Other antitumor agents |
|||||||||
| Prices in pharmacies: — Instructions Lenalidomide-nativ | |||||||||
|
ⓘXEnter drugs for checking interactions through a quick button search . Allopurinol ✘ (incl) Chenodeoxycholic acid ✘ (incl) Lupulus humulus ✘ (incl) Orthomol Junior C plus ✘ |
|
ⓘX diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘXAnalogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Lenalidomide | 480-1128€ |
| ≈100% | neutral Revlimid | 1328€ |
| ≈100% | neutral Lenalidomide Canon | — |
| ≈100% | neutral Lenalidomide-KRKA | — |
| ≈100% | neutral Lenalidomide-TL | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘXAnalogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 64% 162.6€ Милатиб neutral [Bortezomib]
- 64% 136.3€ Бартизар neutral [Bortezomib]
- 64% — Verozomib neutral [Bortezomib]
- 64% 104.5€ Велмиб3.5 neutral [Bortezomib]
- 64% 140-149.4€ Velcade neutral [Bortezomib]
- 64% — Боратерин neutral [Bortezomib]
- 52% — Бортезомиб Канон neutral [Bortezomib]
- 52% — Майборте neutral [Bortezomib]
- 51% — Брукинза neutral [Zanubrutinib]
- 50% — Калквенс Т neutral [Akalabrutinib]
- 50% 6132.2€ Mozobil neutral [Plerixafor]
- 50% 3947.9€ Калквенс neutral [Akalabrutinib]
- 50% — Акалабрутиниб-Промомед neutral [Akalabrutinib]
- 48% — Fludarabine-TL Negative 🔍 [Fludarabine]
- 48% 210€ Flidarin Negative 🔍 [Fludarabine]
- 47% 1440€ Venclexta neutral [Venetoclax]
- 44% — Флутотера Negative 🔍 [Fludarabine]
- 44% — Fludarabine-Ebewe Negative 🔍 [Fludarabine]
- 44% 201.3€ Fludarabel Negative 🔍 [Fludarabine]
- 44% 221€ Fludara Negative 🔍 [Fludarabine]
- 44% 15.2€ Fludarabine-Actavis Negative 🔍 [Fludarabine]
- 44% — Fludarabine phosphate Negative 🔍 [Fludarabine]
- 44% 32.6€ Vero-Fludarabin Negative 🔍 [Fludarabine]
- 44% 14.7-21.7€ Fludarabine-Teva Negative 🔍 [Fludarabine]
- 44% 363€ Fluguarda Negative 🔍 [Fludarabine]
- 43% 790€ Kyprolis neutral [Carfilzomib]
- 42% — Factor tumor necrosis-thymosine alpha-1 recombinant neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 42% — Metvix neutral [Methylaminolevulinate]
- 42% 15.2-27.8€ Цервикон -ДИМ neutral [Diindolylmethane]
- 41% 45-106€ Рибомустин Negative 🔍 [Bendamustine]
- 41% — Дарбинес Negative 🔍 [Fludarabine]
- 41% 91.7€ Boramilan neutral [Bortezomib]
- 41% — Ибрутиниб-Промомед neutral [Ibrutinib]
- 41% — Ибрутиниб Фармасинтез neutral [Ibrutinib]
- 41% — Арбрувия neutral [Ibrutinib]
- 41% — Ибрутиниб-АМЕДАРТ neutral [Ibrutinib]
- 41% — Fludarabine Negative 🔍 [Fludarabine]
- 40% — Карфилзомиб-Гленмарк neutral [Carfilzomib]
- 40% — Карфилзомиб-промомед neutral [Carfilzomib]
- 40% 2964.5€ Пикрэй neutral [Alpelisib]
- 40% — Карфилзомиб авексима neutral [Carfilzomib]
- 40% — Карфилзомиб Фармасинтез neutral [Carfilzomib]
- 40% — Карфилза neutral [Carfilzomib]
- 40% — Карфилзомиб Дж neutral [Carfilzomib]
- 38% 150€ Bortezol neutral [Bortezomib]
- 35% 2417.8€ Ninlaro neutral [Ixazomib]
- 35% 89-120.6€ Refnot neutral [Tumor necrosis factor-thymosine alpha-1 recombinant]
- 35% 927.6€ Oncaspar neutral [Pegaspargase and more 1Asparaginase]
- 34% — Proxifeine filmcoated tablets 0,25 g (enterosoluble) neutral [Proxifeine]
- 34% — Proxifeine solution for injections neutral [Proxifeine]
Learn more about the selection of analogues
▶
- The drug has «Lenalidomide-nativ» 16 full analogs, the cheapest - Lenalidomide (480-1128€); 51 analog by action, the most similar - Velcade (140-149.4€).
- Medical online service has selected the best substitutes for Lenalidomide-nativ based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Lenalidomide-nativ to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.